What’s New?
What’s New?
Future Medicine Publishes Adelphi’s Insights on Mantle Cell Lymphoma
We are delighted that our article ‘Stated preferences for relapsed or refractory mantle cell lymphoma treatments in Sweden and Germany’ has been published by Future Medicine. The article is based on work that Adelphi Research conducted with Janssen where we aimed to...
Adelphi Donates Easter Eggs to Local Foodbank
In light of the current COVID-19 situation, this year our UK office decided to donate our company Easter eggs to Silklife Foodbank in Macclesfield. In total, across the Adelphi Group companies, we have donated over 200 eggs! Even during this pandemic, Silklife...
I Am Patient – COVID-19
As we deal with the current COVID-19 pandemic, we would like to assure you that Adelphi Group is taking every step to ensure the safety and wellbeing of all our staff, families, friends and communities. All staff worldwide are working from home and following...
Supporting our Local Communities
Manna on Main Street Our team in the US has been volunteering at our local Manna on Main Street Soup Kitchen. For almost 40 years, the staff at Manna on Main Street Soup Kitchen have worked tirelessly to help the less fortunate in the community of Lansdale,...
Rare Disease Day Fundraising
Today, Adelphi Research invited everyone in the team as well as the wider Adelphi Group to join us in raising money for Rare Disease Day. We decided to set up several different fundraising activities to help raise money for the event. These activities included a bake...
Can Chatbots Add Value in Pharma Market Research?
Artificial Intelligence (AI) is certainly a top trend in pharma market research at the moment, but we haven’t seen too many examples of it actually in action. We have therefore conducted research to enable us to offer real-life cases of AI in action and we’re sharing...
Why We Illuminate
Take a look at our latest podcast on what’s cooking in Adelphi’s illuminate innovation lab. We’ll share why continuous innovation is key to us and how we develop our latest innovations. Get...
Targeting and Engaging Stakeholders in Different and Impactful Ways
An influx of new treatments including cancer immunotherapies, CAR-T and other novel Mechanism of Actions have and continue to enter the market. This rapid influx has led to confusion across the positioning of key brands for many oncologists. Adelphi has addressed this...
Shaping the way Brands Communicate
The oncology landscape has changed dramatically in recent years with an influx of new treatments including immunotherapies, CAR-T and other novel MOAs entering the market. The influx of change has meant Oncologists are confused and unable to clearly distinguish across...
Adelphi Informs NICE Guidance
NICE has used Adelphi’s research project as a pilot to inform guidance to set standards around patient preference study design. Adelphi’s client wanted a patient preference study that would stand up to NICE scrutiny for their HTA submission. Together with our client,...
Driving Changes in Healthcare Regulation
Adelphi's work with Rethink Mental Illness has helped bring about significant changes to the Mental Health Act. Our work involved investigating the level of choice and involvement people with severe mental illness have when detained under the current Mental Health...
Adelphi Research presents AI at two Global Conferences
We have been sharing key case studies on How Artificial Intelligence can add value in PMR at global conferences. Recently our team presented at PMRC in Newark, NJ, USA and at the EphMRA Meeting in Basel, Switzerland. Adelphi Research has developed two specific case...
Privacy Policy | Cookie Notice | Privacy Shield | California Consumer Privacy | Recruitment Privacy Notice
Copyright © 2020 - 2024 Adelphi Research | Designed by Embrace Marketing Ltd
Company Reg No: 1975338 Registered Office : Bankside3 90-100 Southwark St, London SE1 0SW